查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1812388

生物製剂市场

Biologics Market
出版日期: | 出版商: Transparency Market Research | 英文 213 Pages | 商品交期: 2-10个工作天内

价格

生物製剂市场 - 报告范围

TMR 的全球生物製剂市场报告研究了过去和当前的成长趋势和机会，以获得 2025 年至 2035 年预测期内市场指标的宝贵见解。该报告提供了 2025 年至 2035 年期间全球生物製剂市场的收入，以 2025 年为基准年，2035 年为预测年。该报告也提供了 2025 年至 2035 年全球生物製剂市场的年复合成长率(CAGR %)。

本报告经过广泛的研究后编写。主要研究工作量较大，分析师访问了关键意见领袖、产业领袖和舆论领袖。次要研究则参考了主要厂商的产品资料、年度报告、新闻稿和相关文件，以了解两轮车导航显示器市场。

市场概况
2024年的市场价值 4488亿美元
2035年的市场价值 11402亿美元
复合年增长率 8.8%

本报告深入探讨了全球两轮车导航显示器市场的竞争格局。报告确定了全球生物製剂市场的主要参与者，并根据其各项属性进行了分析。本报告对全球生物製剂市场参与者的属性进行了分析，涵盖公司概况、财务状况、近期发展和 SWOT 分析。

目录

第一章：前言

第二章：假设与研究方法

第三章：执行摘要：全球市场

第四章：市场概况

  • 介绍
  • 概述
  • 市场动态
  • 2020年至2035年全球生物製剂市场分析与预测

第五章：关键见解

  • 重要产业事件
  • 波特五力分析
  • PESTEL分析
  • 疾病盛行率和发生率
  • 管道分析
  • 主要国家/地区的监管情况
  • 主要国家/地区报销情况
  • 定价趋势
  • 治疗方案和选项
  • 最终用户偏好

第六章：全球市场分析与预测：依产品类型

  • 介绍与定义
  • 主要发现/进展
  • 市场价值预测：依产品类型，2020 年至 2035 年
    • 单株抗体
    • 重组蛋白
    • 疫苗
    • 细胞和基因疗法产品
    • 其他的
  • 市场吸引力分析：按产品类型

第七章：全球市场分析与预测：依指标

  • 介绍与定义
  • 主要发现/进展
  • 市场价值预测：按适应症，2020 年至 2035 年
    • 肿瘤学
    • 自体免疫和免疫疾病
    • 血液系统疾病
    • 传染病
    • 其他的
  • 市场吸引力分析：按适应症

第八章：全球市场分析与预测：依製造业

  • 介绍与定义
  • 主要发现/进展
  • 市场价值预测：依製造业，2020 年至 2035 年
    • 外包
    • 内部
  • 市场吸引力分析：按製造业

第九章：全球市场分析与预测：按配销通路

  • 介绍与定义
  • 主要发现/进展
  • 市场价值预测：按配销通路，2020年至2035年
    • 零售药局
    • 医院药房
    • 网路药局
  • 市场吸引力分析：按配销通路

第十章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2020年至2035年
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 各地区市场吸引力

第 11 章：北美市场分析与预测

第十二章：欧洲市场分析与预测

第十三章：亚太市场分析与预测

第 14 章：拉丁美洲市场分析与预测

第 15 章：中东和非洲市场分析与预测

第 16 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：按公司（2024年）
  • 公司简介
    • AbbVie, Inc.
    • Amgen
    • AstraZeneca plc
    • Bristol-Myers Squibb Company
    • Eli Lilly & Company
    • Gilead Sciences, Inc.
    • GSK plc
    • Johnson & Johnson Services, Inc.
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer, Inc.
    • F. Hoffmann-La Roche AG
    • Regeneron Pharmaceuticals Inc.
Product Code: TMRGL15509

Biologics Market - Scope of Report

TMR's report on the global Biologics Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the Market during the forecast period from 2025 to 2035. The report provides revenue of the global Biologics Market for the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Biologics Market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Biologics Market .

Market Snapshot
Market Value in 2024US$ 448.8 Bn
Market Value in 2035US$ 1140.2 Bn
CAGR8.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Biologics Market .

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Biologics Market. These serve as valuable tools for existing Market players as well as for entities interested in participating in the global Biologics Market .

The report delves into the competitive landscape of the global Biologics Market. Key players operating in the global Biologics Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Biologics Market profiled in this report.

Key Questions Answered in Global Biologics Market Report:

  • What are the opportunities in the global Biologics Market ?
  • What are the major drivers, restraints, opportunities, and threats in the Market ?
  • Which regional Market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the Market positions of different companies operating in the global Market ?

Biologics Market - Research Objectives and Research Approach

The comprehensive report on the global Biologics Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the Market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the Market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Biologics Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the Market share for each of these at the end of 2035 has been provided. Such valuable insights enable Market stakeholders in making informed business decisions for investment in the global Biologics Market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Biologics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Biologics Market Analysis and Forecast, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Key Industry Events
  • 5.2. Porter's Five Forces Analysis
  • 5.3. PESTEL Analysis
  • 5.4. Disease Prevalence & Incidence Rate
  • 5.5. Pipeline Analysis
  • 5.6. Regulatory Scenario by Key Countries/Regions
  • 5.7. Reimbursement Scenario by Key Countries/Regions
  • 5.8. Pricing Trends
  • 5.9. Treatment Algorithm & Options
  • 5.10. End-user Preference

6. Global Biologics Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2020 to 2035
    • 6.3.1. Monoclonal Antibodies
    • 6.3.2. Recombinant Proteins
    • 6.3.3. Vaccines
    • 6.3.4. Cell & Gene Therapy Products
    • 6.3.5. Others
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Biologics Market Analysis and Forecast, by Indication

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Indication, 2020 to 2035
    • 7.3.1. Oncology
    • 7.3.2. Autoimmune & Immunological Disorders
    • 7.3.3. Hematological Disorders
    • 7.3.4. Infectious Diseases
    • 7.3.5. Others
  • 7.4. Market Attractiveness Analysis, by Indication

8. Global Biologics Market Analysis and Forecast, by Manufacturing

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Manufacturing, 2020 to 2035
    • 8.3.1. Outsourced
    • 8.3.2. In-house
  • 8.4. Market Attractiveness Analysis, by Manufacturing

9. Global Biologics Market Analysis and Forecast, by Distribution Channel

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Distribution Channel, 2020 to 2035
    • 9.3.1. Retail Pharmacies
    • 9.3.2. Hospital Pharmacies
    • 9.3.3. Online Pharmacies
  • 9.4. Market Attractiveness Analysis, by Distribution Channel

10. Global Biologics Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2020 to 2035
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Region

11. North America Biologics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 11.2.1. Monoclonal Antibodies
    • 11.2.2. Recombinant Proteins
    • 11.2.3. Vaccines
    • 11.2.4. Cell & Gene Therapy Products
    • 11.2.5. Others
  • 11.3. Market Value Forecast, by Indication, 2020 to 2035
    • 11.3.1. Oncology
    • 11.3.2. Autoimmune & Immunological Disorders
    • 11.3.3. Hematological Disorders
    • 11.3.4. Infectious Diseases
    • 11.3.5. Others
  • 11.4. Market Value Forecast, by Manufacturing, 2020 to 2035
    • 11.4.1. Outsourced
    • 11.4.2. In-house
  • 11.5. Market Value Forecast, by Distribution Channel, 2020 to 2035
    • 11.5.1. Retail Pharmacies
    • 11.5.2. Hospital Pharmacies
    • 11.5.3. Online Pharmacies
  • 11.6. Market Value Forecast, by Country, 2020 to 2035
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product Type
    • 11.7.2. By Indication
    • 11.7.3. By Manufacturing
    • 11.7.4. By Distribution Channel
    • 11.7.5. By Country

12. Europe Biologics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 12.2.1. Monoclonal Antibodies
    • 12.2.2. Recombinant Proteins
    • 12.2.3. Vaccines
    • 12.2.4. Cell & Gene Therapy Products
    • 12.2.5. Others
  • 12.3. Market Value Forecast, by Indication, 2020 to 2035
    • 12.3.1. Oncology
    • 12.3.2. Autoimmune & Immunological Disorders
    • 12.3.3. Hematological Disorders
    • 12.3.4. Infectious Diseases
    • 12.3.5. Others
  • 12.4. Market Value Forecast, by Manufacturing, 2020 to 2035
    • 12.4.1. Outsourced
    • 12.4.2. In-house
  • 12.5. Market Value Forecast, by Distribution Channel, 2020 to 2035
    • 12.5.1. Retail Pharmacies
    • 12.5.2. Hospital Pharmacies
    • 12.5.3. Online Pharmacies
  • 12.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Switzerland
    • 12.6.7. The Netherlands
    • 12.6.8. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product Type
    • 12.7.2. By Indication
    • 12.7.3. By Manufacturing
    • 12.7.4. By Distribution Channel
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Biologics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 13.2.1. Monoclonal Antibodies
    • 13.2.2. Recombinant Proteins
    • 13.2.3. Vaccines
    • 13.2.4. Cell & Gene Therapy Products
    • 13.2.5. Others
  • 13.3. Market Value Forecast, by Indication, 2020 to 2035
    • 13.3.1. Oncology
    • 13.3.2. Autoimmune & Immunological Disorders
    • 13.3.3. Hematological Disorders
    • 13.3.4. Infectious Diseases
    • 13.3.5. Others
  • 13.4. Market Value Forecast, by Manufacturing, 2020 to 2035
    • 13.4.1. Outsourced
    • 13.4.2. In-house
  • 13.5. Market Value Forecast, by Distribution Channel, 2020 to 2035
    • 13.5.1. Retail Pharmacies
    • 13.5.2. Hospital Pharmacies
    • 13.5.3. Online Pharmacies
  • 13.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 13.6.1. China
    • 13.6.2. India
    • 13.6.3. Japan
    • 13.6.4. South Korea
    • 13.6.5. Australia & New Zealand
    • 13.6.6. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product Type
    • 13.7.2. By Indication
    • 13.7.3. By Manufacturing
    • 13.7.4. By Distribution Channel
    • 13.7.5. By Country/Sub-region

14. Latin America Biologics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 14.2.1. Monoclonal Antibodies
    • 14.2.2. Recombinant Proteins
    • 14.2.3. Vaccines
    • 14.2.4. Cell & Gene Therapy Products
    • 14.2.5. Others
  • 14.3. Market Value Forecast, by Indication, 2020 to 2035
    • 14.3.1. Oncology
    • 14.3.2. Autoimmune & Immunological Disorders
    • 14.3.3. Hematological Disorders
    • 14.3.4. Infectious Diseases
    • 14.3.5. Others
  • 14.4. Market Value Forecast, by Manufacturing, 2020 to 2035
    • 14.4.1. Outsourced
    • 14.4.2. In-house
  • 14.5. Market Value Forecast, by Distribution Channel, 2020 to 2035
    • 14.5.1. Retail Pharmacies
    • 14.5.2. Hospital Pharmacies
    • 14.5.3. Online Pharmacies
  • 14.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Argentina
    • 14.6.4. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product Type
    • 14.7.2. By Indication
    • 14.7.3. By Manufacturing
    • 14.7.4. By Distribution Channel
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Biologics Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 15.2.1. Monoclonal Antibodies
    • 15.2.2. Recombinant Proteins
    • 15.2.3. Vaccines
    • 15.2.4. Cell & Gene Therapy Products
    • 15.2.5. Others
  • 15.3. Market Value Forecast, by Indication, 2020 to 2035
    • 15.3.1. Oncology
    • 15.3.2. Autoimmune & Immunological Disorders
    • 15.3.3. Hematological Disorders
    • 15.3.4. Infectious Diseases
    • 15.3.5. Others
  • 15.4. Market Value Forecast, by Manufacturing, 2020 to 2035
    • 15.4.1. Outsourced
    • 15.4.2. In-house
  • 15.5. Market Value Forecast, by Distribution Channel, 2020 to 2035
    • 15.5.1. Retail Pharmacies
    • 15.5.2. Hospital Pharmacies
    • 15.5.3. Online Pharmacies
  • 15.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Product Type
    • 15.7.2. By Indication
    • 15.7.3. By Manufacturing
    • 15.7.4. By Distribution Channel
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Market Share Analysis, by Company (2024)
  • 16.3. Company Profiles
    • 16.3.1. AbbVie, Inc.
      • 16.3.1.1. Company Overview
      • 16.3.1.2. Financial Overview
      • 16.3.1.3. Product Portfolio
      • 16.3.1.4. Business Strategies
      • 16.3.1.5. Recent Developments
    • 16.3.2. Amgen
      • 16.3.2.1. Company Overview
      • 16.3.2.2. Financial Overview
      • 16.3.2.3. Product Portfolio
      • 16.3.2.4. Business Strategies
      • 16.3.2.5. Recent Developments
    • 16.3.3. AstraZeneca plc
      • 16.3.3.1. Company Overview
      • 16.3.3.2. Financial Overview
      • 16.3.3.3. Product Portfolio
      • 16.3.3.4. Business Strategies
      • 16.3.3.5. Recent Developments
    • 16.3.4. Bristol-Myers Squibb Company
      • 16.3.4.1. Company Overview
      • 16.3.4.2. Financial Overview
      • 16.3.4.3. Product Portfolio
      • 16.3.4.4. Business Strategies
      • 16.3.4.5. Recent Developments
    • 16.3.5. Eli Lilly & Company
      • 16.3.5.1. Company Overview
      • 16.3.5.2. Financial Overview
      • 16.3.5.3. Product Portfolio
      • 16.3.5.4. Business Strategies
      • 16.3.5.5. Recent Developments
    • 16.3.6. Gilead Sciences, Inc.
      • 16.3.6.1. Company Overview
      • 16.3.6.2. Financial Overview
      • 16.3.6.3. Product Portfolio
      • 16.3.6.4. Business Strategies
      • 16.3.6.5. Recent Developments
    • 16.3.7. GSK plc
      • 16.3.7.1. Company Overview
      • 16.3.7.2. Financial Overview
      • 16.3.7.3. Product Portfolio
      • 16.3.7.4. Business Strategies
      • 16.3.7.5. Recent Developments
    • 16.3.8. Johnson & Johnson Services, Inc.
      • 16.3.8.1. Company Overview
      • 16.3.8.2. Financial Overview
      • 16.3.8.3. Product Portfolio
      • 16.3.8.4. Business Strategies
      • 16.3.8.5. Recent Developments
    • 16.3.9. Merck & Co., Inc.
      • 16.3.9.1. Company Overview
      • 16.3.9.2. Financial Overview
      • 16.3.9.3. Product Portfolio
      • 16.3.9.4. Business Strategies
      • 16.3.9.5. Recent Developments
    • 16.3.10. Novartis AG
      • 16.3.10.1. Company Overview
      • 16.3.10.2. Financial Overview
      • 16.3.10.3. Product Portfolio
      • 16.3.10.4. Business Strategies
      • 16.3.10.5. Recent Developments
    • 16.3.11. Pfizer, Inc.
      • 16.3.11.1. Company Overview
      • 16.3.11.2. Financial Overview
      • 16.3.11.3. Product Portfolio
      • 16.3.11.4. Business Strategies
      • 16.3.11.5. Recent Developments
    • 16.3.12. F. Hoffmann-La Roche AG
      • 16.3.12.1. Company Overview
      • 16.3.12.2. Financial Overview
      • 16.3.12.3. Product Portfolio
      • 16.3.12.4. Business Strategies
      • 16.3.12.5. Recent Developments
    • 16.3.13. Regeneron Pharmaceuticals Inc.
      • 16.3.13.1. Company Overview
      • 16.3.13.2. Financial Overview
      • 16.3.13.3. Product Portfolio
      • 16.3.13.4. Business Strategies
      • 16.3.13.5. Recent Developments

List of Tables

  • Table 01: Global Biologics Market Value (US$ Mn) Forecast, by Product Type, 2020 to 2035
  • Table 02: Global Biologics Market Value (US$ Mn) Forecast, By Indication, 2020 to 2035
  • Table 03: Global Biologics Market Value (US$ Mn) Forecast, By Manufacturing, 2020 to 2035
  • Table 04: Global Biologics Market Value (US$ Mn) Forecast, by Distribution Channel, 2020 to 2035
  • Table 05: Global Biologics Market Value (US$ Mn) Forecast, By Region, 2020 to 2035
  • Table 06: North America Biologics Market Value (US$ Mn) Forecast, by Country, 2020 to 2035
  • Table 07: North America Biologics Market Value (US$ Mn) Forecast, by Product Type, 2020 to 2035
  • Table 08: North America Biologics Market Value (US$ Mn) Forecast, by Indication, 2020 to 2035
  • Table 09: North America Biologics Market Value (US$ Mn) Forecast, By Manufacturing, 2020 to 2035
  • Table 10: North America Biologics Market Value (US$ Mn) Forecast, by Distribution Channel, 2020 to 2035
  • Table 11: Europe Biologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020 to 2035
  • Table 12: Europe Biologics Market Value (US$ Mn) Forecast, by Product Type, 2020 to 2035
  • Table 13: Europe Biologics Market Value (US$ Mn) Forecast, by Indication, 2020 to 2035
  • Table 14: Europe Biologics Market Value (US$ Mn) Forecast, By Manufacturing, 2020 to 2035
  • Table 15: Europe Biologics Market Value (US$ Mn) Forecast, by Distribution Channel, 2020 to 2035
  • Table 16: Asia Pacific Biologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020 to 2035
  • Table 17: Asia Pacific Biologics Market Value (US$ Mn) Forecast, by Product Type, 2020 to 2035
  • Table 18: Asia Pacific Biologics Market Value (US$ Mn) Forecast, by Indication, 2020 to 2035
  • Table 19: Asia Pacific Biologics Market Value (US$ Mn) Forecast, By Manufacturing, 2020 to 2035
  • Table 20: Asia Pacific Biologics Market Value (US$ Mn) Forecast, by Distribution Channel, 2020 to 2035
  • Table 21: Latin America Biologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020 to 2035
  • Table 22: Latin America Biologics Market Value (US$ Mn) Forecast, by Product Type, 2020 to 2035
  • Table 23: Latin America Biologics Market Value (US$ Mn) Forecast, by Indication, 2020 to 2035
  • Table 24: Latin America Biologics Market Value (US$ Mn) Forecast, By Manufacturing, 2020 to 2035
  • Table 25: Latin America Biologics Market Value (US$ Mn) Forecast, by Distribution Channel, 2020 to 2035
  • Table 26: Middle East & Africa Biologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020 to 2035
  • Table 27: Middle East and Africa Biologics Market Value (US$ Mn) Forecast, by Product Type, 2020 to 2035
  • Table 28: Middle East and Africa Biologics Market Value (US$ Mn) Forecast, by Indication, 2020 to 2035
  • Table 29: Middle East and Africa Biologics Market Value (US$ Mn) Forecast, By Manufacturing, 2020 to 2035
  • Table 30: Middle East and Africa Biologics Market Value (US$ Mn) Forecast, by Distribution Channel, 2020 to 2035

List of Figures

  • Figure 01: Global Biologics Market Value Share Analysis, by Product Type, 2024 and 2035
  • Figure 02: Global Biologics Market Attractiveness Analysis, by Product Type, 2025 to 2035
  • Figure 03: Global Biologics Market Revenue (US$ Mn), by Monoclonal Antibodies, 2020 to 2035
  • Figure 04: Global Biologics Market Revenue (US$ Mn), by Recombinant Proteins, 2020 to 2035
  • Figure 05: Global Biologics Market Revenue (US$ Mn), by Vaccines, 2020 to 2035
  • Figure 06: Global Biologics Market Revenue (US$ Mn), by Cell & Gene Therapy Products, 2020 to 2035
  • Figure 07: Global Biologics Market Revenue (US$ Mn), by Others, 2020 to 2035
  • Figure 08: Global Biologics Market Value Share Analysis, by Indication, 2024 and 2035
  • Figure 09: Global Biologics Market Attractiveness Analysis, by Indication, 2025 to 2035
  • Figure 10: Global Biologics Market Revenue (US$ Mn), by Oncology, 2020 to 2035
  • Figure 11: Global Biologics Market Revenue (US$ Mn), by Autoimmune & Immunological Disorders, 2020 to 2035
  • Figure 12: Global Biologics Market Revenue (US$ Mn), by Hematological Disorders, 2020 to 2035
  • Figure 13: Global Biologics Market Revenue (US$ Mn), by Infectious Diseases, 2020 to 2035
  • Figure 14: Global Biologics Market Revenue (US$ Mn), by Others, 2020 to 2035
  • Figure 15: Global Biologics Market Value Share Analysis, by Manufacturing, 2024 and 2035
  • Figure 16: Global Biologics Market Attractiveness Analysis, by Manufacturing, 2025 to 2035
  • Figure 17: Global Biologics Market Revenue (US$ Mn), by Outsourced, 2020 to 2035
  • Figure 18: Global Biologics Market Revenue (US$ Mn), by In-house, 2020 to 2035
  • Figure 19: Global Biologics Market Value Share Analysis, by Distribution Channel, 2024 and 2035
  • Figure 20: Global Biologics Market Attractiveness Analysis, by Distribution Channel, 2025 to 2035
  • Figure 21: Global Biologics Market Revenue (US$ Mn), by Retail Pharmacies , 2020 to 2035
  • Figure 22: Global Biologics Market Revenue (US$ Mn), by Hospital Pharmacies, 2020 to 2035
  • Figure 23: Global Biologics Market Revenue (US$ Mn), by Online Pharmacies, 2020 to 2035
  • Figure 24: Global Biologics Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 25: Global Biologics Market Attractiveness Analysis, By Region, 2025 to 2035
  • Figure 26: North America Biologics Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 27: North America Biologics Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 28: North America Biologics Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 29: North America Biologics Market Value Share Analysis, by Product Type, 2024 and 2035
  • Figure 30: North America Biologics Market Attractiveness Analysis, by Product Type, 2025 to 2035
  • Figure 31: North America Biologics Market Value Share Analysis, by Indication, 2025 to 2035
  • Figure 32: North America Biologics Market Attractiveness Analysis, by Indication, 2025 to 2035
  • Figure 33: North America Biologics Market Value Share Analysis, by Manufacturing, 2024 and 2035
  • Figure 34: North America Biologics Market Attractiveness Analysis, by Manufacturing, 2025 to 2035
  • Figure 35: North America Biologics Market Value Share Analysis, by Distribution Channel, 2024 and 2035
  • Figure 36: North America Biologics Market Attractiveness Analysis, by Distribution Channel, 2025 to 2035
  • Figure 37: Europe Biologics Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 38: Europe Biologics Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 39: Europe Biologics Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 40: Europe Biologics Market Value Share Analysis, by Product Type, 2024 and 2035
  • Figure 41: Europe Biologics Market Attractiveness Analysis, by Product Type, 2025 to 2035
  • Figure 42: Europe Biologics Market Value Share Analysis, by Indication, 2025 to 2035
  • Figure 43: Europe Biologics Market Attractiveness Analysis, by Indication, 2024 and 2035
  • Figure 44: Europe Biologics Market Value Share Analysis, By Manufacturing, 2024 and 2035
  • Figure 45: Europe Biologics Market Attractiveness Analysis, By Manufacturing, 2025 to 2035
  • Figure 46: Europe Biologics Market Value Share Analysis, by Distribution Channel, 2024 and 2035
  • Figure 47: Europe Biologics Market Attractiveness Analysis, by Distribution Channel, 2025 to 2035
  • Figure 48: Asia Pacific Biologics Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 49: Asia Pacific Biologics Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 50: Asia Pacific Biologics Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 51: Asia Pacific Biologics Market Value Share Analysis, by Product Type, 2024 and 2035
  • Figure 52: Asia Pacific Biologics Market Attractiveness Analysis, by Product Type, 2025 to 2035
  • Figure 53: Asia Pacific Biologics Market Value Share Analysis, by Indication, 2025 to 2035
  • Figure 54: Asia Pacific Biologics Market Attractiveness Analysis, by Indication, 2024 and 2035
  • Figure 55: Asia Pacific Biologics Market Value Share Analysis, By Manufacturing, 2024 and 2035
  • Figure 56: Asia Pacific Biologics Market Attractiveness Analysis, By Manufacturing, 2025 to 2035
  • Figure 57: Asia Pacific Biologics Market Value Share Analysis, by Distribution Channel, 2024 and 2035
  • Figure 58: Asia Pacific Biologics Market Attractiveness Analysis, by Distribution Channel, 2025 to 2035
  • Figure 59: Latin America Biologics Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 60: Latin America Biologics Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 61: Latin America Biologics Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 62: Latin America Biologics Market Value Share Analysis, by Product Type, 2024 and 2035
  • Figure 63: Latin America Biologics Market Attractiveness Analysis, by Product Type, 2025 to 2035
  • Figure 64: Latin America Biologics Market Value Share Analysis, by Indication, 2025 to 2035
  • Figure 65: Latin America Biologics Market Attractiveness Analysis, by Indication, 2024 and 2035
  • Figure 66: Latin America Biologics Market Value Share Analysis, By Manufacturing, 2024 and 2035
  • Figure 67: Latin America Biologics Market Attractiveness Analysis, By Manufacturing, 2025 to 2035
  • Figure 68: Latin America Biologics Market Value Share Analysis, by Distribution Channel, 2024 and 2035
  • Figure 69: Latin America Biologics Market Attractiveness Analysis, by Distribution Channel, 2025 to 2035
  • Figure 70: Middle East & Africa Biologics Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 71: Middle East & Africa Biologics Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 72: Middle East & Africa Biologics Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 73: Middle East and Africa Biologics Market Value Share Analysis, by Product Type, 2024 and 2035
  • Figure 74: Middle East and Africa Biologics Market Attractiveness Analysis, by Product Type, 2025 to 2035
  • Figure 75: Middle East and Africa Biologics Market Value Share Analysis, by Indication, 2025 to 2035
  • Figure 76: Middle East and Africa Biologics Market Attractiveness Analysis, by Indication, 2024 and 2035
  • Figure 77: Middle East and Africa Biologics Market Value Share Analysis, by Manufacturing, 2024 and 2035
  • Figure 78: Middle East and Africa Biologics Market Attractiveness Analysis, By Manufacturing, 2025 to 2035
  • Figure 79: Middle East and Africa Biologics Market Value Share Analysis, by Distribution Channel, 2024 and 2035
  • Figure 80: Middle East and Africa Biologics Market Attractiveness Analysis, by Distribution Channel, 2025 to 2035